Ocugen, Inc. (OCGN)
1.37
-0.04
(-2.84%)
USD |
NASDAQ |
Aug 27, 16:00
1.37
0.00 (0.00%)
After-Hours: 20:00
Ocugen 1 Year Total Returns (Daily) : 31.73% for Aug. 27, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 27, 2026 | 31.73% |
| August 26, 2026 | 35.58% |
| August 25, 2026 | 34.62% |
| August 24, 2026 | 34.65% |
| August 21, 2026 | 37.62% |
| August 20, 2026 | 37.62% |
| August 19, 2026 | 48.00% |
| August 18, 2026 | 28.85% |
| August 17, 2026 | 30.95% |
| August 14, 2026 | 31.07% |
| August 13, 2026 | 31.07% |
| August 12, 2026 | 35.92% |
| August 11, 2026 | 39.70% |
| August 10, 2026 | 31.21% |
| August 07, 2026 | 28.00% |
| August 06, 2026 | 29.40% |
| August 05, 2026 | 34.03% |
| August 04, 2026 | 31.00% |
| August 03, 2026 | 25.81% |
| July 31, 2026 | 19.42% |
| July 30, 2026 | 17.76% |
| July 29, 2026 | 15.53% |
| July 28, 2026 | 20.39% |
| July 27, 2026 | 15.60% |
| July 24, 2026 | 8.04% |
| Date | Value |
|---|---|
| July 23, 2026 | 8.55% |
| July 22, 2026 | 25.24% |
| July 21, 2026 | 28.71% |
| July 20, 2026 | 30.39% |
| July 17, 2026 | 36.00% |
| July 16, 2026 | 31.73% |
| July 15, 2026 | 33.64% |
| July 14, 2026 | 28.83% |
| July 13, 2026 | 23.68% |
| July 10, 2026 | 27.83% |
| July 09, 2026 | 30.09% |
| July 08, 2026 | 42.86% |
| July 07, 2026 | 54.64% |
| July 06, 2026 | 55.69% |
| July 02, 2026 | 63.00% |
| July 01, 2026 | 60.16% |
| June 30, 2026 | 57.67% |
| June 29, 2026 | 69.70% |
| June 26, 2026 | 45.63% |
| June 25, 2026 | 31.73% |
| June 24, 2026 | 34.30% |
| June 23, 2026 | 40.66% |
| June 22, 2026 | 21.70% |
| June 18, 2026 | 13.76% |
| June 17, 2026 | 12.84% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| CytomX Therapeutics, Inc. | 65.22% |
| ACADIA Pharmaceuticals, Inc. | 11.89% |
| Biogen, Inc. | 62.44% |
| Gilead Sciences, Inc. | 34.08% |
| MannKind Corp. | -10.18% |